| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |